Novolog 100 unit/ML vial 10ML

Ended Awarded

Contract number
SPE2DR26F71RA
Awardee
Awarding agency
Obligated
$13,197

Award facts

Contract value 100% obligated
$13,197.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $13,197.03 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/mL vials (10mL). This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order was awarded on October 24, 2025, with an ultimate completion date of October 27, 2025. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle—specifically the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026—which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs globally.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established federal vendor specializing in medical procurement for defense and military healthcare systems. The company's contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Novolog, an insulin product used in diabetes management, aligns with AmerisourceBergen's demonstrated capability in supplying critical medications to support military and veteran healthcare requirements. The DLA Troop Support Medical contract enables the company to supply pharmaceutical commodities to customers including the Defense Health Agency and U.S. Coast Guard, making this delivery order part of a strategic, multi-region pharmaceutical procurement framework designed to ensure consistent medical supply availability across federal healthcare systems.

Quick answers

Who was awarded contract SPE2DR26F71RA?

SPE2DR26F71RA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.

How much is contract SPE2DR26F71RA worth?

The government has obligated $13,197 on SPE2DR26F71RA.

Is contract SPE2DR26F71RA an order under another contract?

Yes. SPE2DR26F71RA is a delivery order under SPE2DR25D1202, an indefinite delivery contract.

Was contract SPE2DR26F71RA competed?

The extent of competition for SPE2DR26F71RA was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award